SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549



                                   FORM 10-QSB


                   Quarterly Report Under Section 13 of 15(d)
                     of the Securities Exchange Act of 1934


For Quarter ended May 31, 1998

commission file number 2-92261


                            WESTBRIDGE RESEARCH GROUP


-------------------------------------------------------------------------------



              California                                  95-3769474
--------------------------------------         --------------------------------
  (State or other jurisdiction or                     (I.R.S. Employer
   incorporation or organization)                    Identification No.)
          1150 Joshua Way
      Vista, California 92083
---------------------------------------
(Address of principal executive office)

Registrant's telephone number, including                (760) 599-8855
area code:                                      -------------------------------


         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes _____ No _____.

         Indicate  the  number of  shares  outstanding  of each of the  issuer's
classes of common stock, as of a recent date:  2,103,438 shares of common stock,
no par value as of May 31, 1998.

                                        


                                        1

<PAGE>



                         PART I - FINANCIAL INFORMATION

                          ITEM 1 - FINANCIAL STATEMENTS

                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

                      CONSOLIDATED CONDENSED BALANCE SHEETS


<TABLE>
                                             MAY 31,                NOV. 30,
                                              1998                   1997
                                           (unaudited)             (audited)
                                        -----------------     -----------------

                                     ASSETS

<S>                                     <C>                    <C> 
                                                         
CURRENT ASSETS
 Cash                                     $  187,111             $  251,781
 Trade accounts receivable, less
  allowance for doubtful accounts of 
  $206 and $206 respectively                 249,923                191,036
 Inventories                                 105,595                 82,059
 Prepaid expenses and other current 
  assets                                      26,002                 14,391
                                          ------------           -----------
          Total Current Assets               568,631                539,267

PROPERTY AND EQUIPMENT                       428,565                416,517
 Less accumulated depreciation              [349,385]              [341,117]
          Net Property and Equipment          79,180                 75,400
PROCESSES AND FORMULAS, net of
  accumulated amortization of $3,010,337 
  and $2,970,168 respectively                 87,031                127,200
PREPAID ROYALTY, net of accumulated
 amortization of $31,860 and $22, 302
 respectively                                164,082                173,640
LONG TERM ACCOUNTS RECEIVABLE, net           130,000                130,000
                                          -----------            -----------
          TOTAL ASSETS                    $1,028,924             $1,045,507
                                          ===========            ===========
</TABLE>



                     See accompanying notes to consolidated
                         condensed financial statements.


                                        2

<PAGE>



                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY
                      CONSOLIDATE CONDENSED BALANCE SHEETS
                                   (Continued)

<TABLE>
                                                 MAY 31,          NOV. 30,
                                                  1998              1997
                                               (unaudited)        (audited)
                                           ------------------- ----------------

                      LIABILITIES AND SHAREHOLDER'S EQUITY
<S>                                           <C>                <C>    
CURRENT LIABILITIES
      Accounts payable                        $   48,738          $  57,396
      Notes payable - related parties            245,554            236,914
      Notes payable                               29,955             29,106
      Accrued expenses                            70,726             95,190
      Current portion of capital
        lease obligation                           3,131              3,845
      Current portion of long-term debt           36,129             39,475
                                              -----------        -----------

          TOTAL CURRENT LIABILITIES              434,233            461,926
Long-term debt                                    10,428             26,067
Deferred rent                                         --              1,284
Capital lease obligations:
      net of current portion                      10,957             11,650
                                               ----------         ----------

          TOTAL LIABILITIES                      455,618            500,927

SHAREHOLDERS' EQUITY
      Common stock, no par value:
      Authorized 9,375,000 shares
      Issued and outstanding 2,103,438 
      shares                                   8,479,854          8,479,854

      Paid in Capital:  Warrants                  95,000             95,000
      Accumulated deficit                     [8,001,548]        [8,030,274]

          TOTAL SHAREHOLDERS' EQUITY             573,306            544,580
                                             ------------       ------------

          TOTAL LIABILITIES &
               SHAREHOLDERS' EQUITY           $1,028,924         $1,045,507
                                              ==========         ==========
</TABLE>



                     See accompanying notes to consolidated
                         condensed financial statements.


                                        3

<PAGE>



                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY
                 CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
                                   (Unaudited)


<TABLE>
                                                                THREE MONTHS                               SIX MONTHS
                                                                ENDED MAY 31                              ENDED MAY 31
                                                           1998               1997                    1998              1997
                                                    ------------------------------------------------------------------------------
<S>                                                       <C>                 <C>                     <C>               <C>    
NET SALES                                                     $ 626,662        $  596,366               $ 788,200         $869,028
COST OF SALES                                                   220,890           171,068                 287,317          239,536
                                                             ----------       -----------             -----------      -----------
GROSS PROFIT                                                    405,772           425,298                 500,883          629,492
                                                             ----------       -----------             -----------       ----------
OPERATING EXPENSES
      Research and development                                   35,497            20,020                  69,708           42,252
      Selling                                                   105,357            72,834                 205,887          125,118
      General and administration                                 58,797            55,606                 115,813          106,907
      Royalties                                                  23,478            22,702                  35,255           37,117
      Amortization of formula                                    20,085            20,084                  40,169           40,169
                                                            -----------       -----------             -----------       ----------

          TOTAL OPERATING EXPENSES                               43,214           191,246                 466,832          351,623
                                                             ----------        ----------              ----------       ----------
      Operating income                                          162,558           234,052                  34,051          277,869

OTHER INCOME (EXPENSE)
      Interest expense                                          [8,492]           [6,855]                [14,664]         [15,663]
      Interest income                                               783               770                   3,009            1,376
      Other income                                                   --                --                   6,330            6,050
                                                          -------------    --------------           -------------     ------------

      Net income                                            $   154,849        $  227,967            $     28,726      $   269,632
                                                            ===========        ==========            ============      ===========

Net income per common share                             $           .07    $          .11         $           .01  $           .13
                                                        ===============    ==============         ===============  ===============

Weighted average common and common                           $2,103,438        $2,103,438              $2,103,438       $2,103,438
      equivalent shares outstanding                          ==========        ==========              ==========       ==========
</TABLE>



                     See accompanying notes to consolidated
                         condensed financial statements.


                                        4

<PAGE>



                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY
                 CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS
                                   (Unaudited)

<TABLE>
                                                                                    SIX MONTHS ENDED
                                                                         MAY 31,                        MAY 31,
                                                                          1998                           1997
                                                                    -----------------  --------- --------------------
<S>                                                                    <C>                           <C>    
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income                                                                 $   28,726                      $  269,632
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
Amortization of prepaid royalty                                                 9,558                           9,558
Depreciation and amortization                                                  48,437                          48,435
Changes in Operating Assets and Liabilities:
      Increase in trade accounts receivable                                  [58,887]                       [235,647]
      Increase in inventories                                                [23,536]                        [13,316]
      Increase in prepaid expenses                                           [11,611]                         [5,984]
      [Decrease] increase in accounts payable                                 [8,658]                          27,143
      Decrease in accrued liabilities                                        [24,464]                        [13,791]
                                                                        -------------                   -------------
Net cash used in provided by operating activities                            [40,435]                          86,030
                                                                        -------------                   -------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment                                           [12,048]                         [2,934]
                                                                        -------------                  --------------
Net cash (used in) investing activities                                      [12,048]                         [2,934]
                                                                        -------------                  --------------
CASH FLOWS FROM FINANCING ACTIVITIES:
      Payments on notes payable                                              [18,985]                        [20,846]
      Decrease in deferred rent                                               [1,284]                         [1,926]
      Payments on capital lease obligations                                   [1,407]                         [2,141]
      Borrowings on notes payable and notes
      payable-related parties                                                   9,489                           9,028
                                                                         ------------                 ---------------
Net Cash used in financing activities                                        [12,187]                        [15,885]
                                                                          -----------                    ------------
[DECREASE] INCREASE IN CASH                                                  [64,670]                          67,211
CASH AT BEGINNING OF PERIOD                                                    51,781                         115,719
                                                                          -----------                     -----------
CASH AT END OF PERIOD                                                       $ 187,111                      $  182,930
                                                                            =========                      ==========
</TABLE>


                     See accompanying notes to consolidated
                         condensed financial statements.


                                        5

<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY


                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



         A.       Basic of Presentation:

                           The  consolidated  balance  sheet as of May 31, 1998,
                  the  consolidated  statement of  operations  for the six-month
                  periods ended May 31, 1998,  and 1997,  respectively,  and the
                  consolidated  statements  of  cash  flows  for  the  six-month
                  periods then ended have been  prepared by the Company  without
                  audit. In the opinion of management,  all  adjustments  (which
                  include only normal recurring  adjustments  except as noted in
                  management's  discussion  and analysis of financial  condition
                  and results of  operations)  necessary  to present  fairly the
                  financial position,  results of operations and changes in cash
                  flows have been made.

                           Certain information and footnote disclosures normally
                  included in financial  statements  prepared in accordance with
                  generally accepted  accounting  principles have been condensed
                  or omitted. It is suggested that these consolidated  financial
                  statements   be  read  in   conjunction   with  the  financial
                  statements  and  notes  thereto  included  in the 1997  Annual
                  Report on Form  10-KSB.  The  results  of  operations  for the
                  quarter ended May 31, 1998, are not necessarily  indicative of
                  the operating results for the full year.

         B.       Reclassification:

                           Certain amounts on the November 30, 1997 consolidated
                  condensed  statement of liabilities and  shareholders'  equity
                  have  been  reclassified  to  conform  to the  current  period
                  presentation.

         C.       Stock Split:

                           On July 17,  1997  the  shareholders  of the  Company
                  voted to execute a one-for-  four  reverse  stock  split.  The
                  reverse stock split was effective for  shareholders  of record
                  on February  6, 1998.  Per share  amounts in the  accompanying
                  financial statements have been restated to give effect for the
                  reverse stock split as if it occurred on December 1, 1996.

         D.       Subsequent Events:

                           None.


                                        6

<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY


                      MANAGEMENT'S DISCUSSION AND ANALYSIS


ITEM 2.  Management's Discussion and Analysis of Financial Condition and 
         Results of Operations.

         Results of Operations:

         Net sales for the three month period ended May 31, 1998 were  $626,662,
representing  an increase of 5% from  $596,366  for the same period in the prior
year.  For the six  month  period  ended  May 31,  1998,  sales  were  $788,200,
representing  a decrease of 9% from $869,028 in the prior year.  The three month
increase is associated  with an increase in existing  customer  sales as well as
the add on of a new  distributor  and  manufacturing  of a new product.  The six
month  decrease is due to negative  weather  conditions  causing a reduction  in
sales of the Company's  foreign markets as well as delayed planting of key crops
in regions of the Company's domestic market.

         Cost of sales as a  percentage  of net sales  increased  to 35% for the
quarter ended May 31, 1998 as compared with 29% for the same period in the prior
year. For the six month period ended May 31, 1998, cost of sales as a percentage
of net sales  increased  to 36% from 28% for the same  period in the prior year.
These increases resulted primarily from an increased  percentage of lower margin
products in the product sales mix.

         Operating  expenses for the three and six month  periods  ended May 31,
1998 increased 27% and 33%, respectively,  compared with the same periods in the
prior year.  These increases are primarily due to increases in selling  expenses
and research and development expenses discussed below.

         Research and development  expenses as a percentage of net sales for the
three and six month  periods  ended May 31,  1998 were 6% and 8%,  respectively,
compared with 3% and 5% for the same periods in the prior year. This increase is
a  result  of an  increase  in  the  research  and  development  staff,  thereby
increasing salaries and wages, and related expenses.

         Selling  expenses  as a  percentage  of net sales for the three and six
month periods ended May 31, 1998 were 17% and 26%,  respectively,  compared with
12% and 14% for the same periods in the prior year.  This  increase is due to an
expansion in the sales and marketing staff and increased advertising.

         General and administrative  expenses in the three and six month periods
ended May 31, 1998  increased  by $3,191 or 6%, and $8,906 or 8%,  respectively,
when compared with the same periods in the prior year.

         Net income for the quarter  ended May 31, 1998 was $154,849 or $.07 per
common share compared with net income of $227,967,  or $.11 per common share for
the same period in the prior year.  This decrease is the result of a decrease in
net sales and an increase  in selling  expenses  and  research  and  development
expenses.

                                        7

<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY


         Income taxes have not been provided for in the  accompanying  financial
statements of operations due to the net operating loss carry forwards  generated
in prior years that are available for carry forward against current year income.



                      MANAGEMENT'S DISCUSSION AND ANALYSIS


Liquidity and Capital Resources:

         The Company has no material commitments for capital expenditures.

         Working  capital  was  $134,398  at May 31,  1998,  up from  $77,341 at
November 30, 1997.

         Based on current  cash flow  projections  management  expects  that the
Company can  continue  operations  for the current  year  without  infusions  of
additional cash.


Impact of Inflation

         The Company does not believe inflation has had a significant  effect on
its operations.


                           PART II - OTHER INFORMATION


ITEM 1.           LEGAL PROCEEDINGS
                  None

ITEM 2.           CHANGES IN SECURITIES
                  None

ITEM 3.           DEFAULTS UPON SENIOR SECURITIES
                  None

ITEM 4.           SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
                  None

ITEM 5.           OTHER INFORMATION
                  None


                                        8

<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY


ITEM 6.           EXHIBITS AND REPORTS ON FORM 8-K

                  A.       EXHIBITS
                           None

                  B.       REPORTS ON FORM 8-K
                           None





                                        9

<PAGE>


                    WESTBRIDGE RESEARCH GROUP AND SUBSIDIARY

                                   SIGNATURES



         Pursuant tot he  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                              WESTBRIDGE RESEARCH GROUP
                                              (Registrant)

                                              /s/ Christine Koenemann
                                              --------------------------------
                                              Christine Koenemann, President
                                              Principal Executive Officer
                                              Principal Financial Officer



                                       10